# Therapeutic Hepatitis C Virus Vaccine

> **NCT04318379** · PHASE1 · UNKNOWN · sponsor: **GeneCure Biotechnologies** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Hepatitis C Infection

## Interventions

- **BIOLOGICAL:** HCVax

## Key facts

- **NCT ID:** NCT04318379
- **Lead sponsor:** GeneCure Biotechnologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-20
- **Primary completion:** 2023-02
- **Final completion:** 2023-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04318379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04318379, "Therapeutic Hepatitis C Virus Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04318379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*